T H 2 cells might contribute to food allergy through both T H 2 cytokine production and defective regulatory function. 13 These studies highlight a growing appreciation of the complexity of the food-specific T-cell response in patients with food allergy.
We hypothesized that clinical PA results from a combination of disordered proinflammatory T H 2 immunity and an antigenspecific defect in regulatory activity, and we tested this hypothesis in well-characterized patient cohorts and healthy control (HC) subjects, including 84 primarily pediatric subjects who underwent a double-blind, placebo-controlled food challenge to peanut. We performed single-cell analysis using flow cytometry and RNA sequencing (RNA-seq) to determine the phenotype of the T-cell response underlying allergy or tolerance to peanut. Our data show that clinical tolerance to foods is associated with immunologic ignorance or anergy, and the defining feature of PA is the presence of antigen-specific cells, including highly differentiated, tissue-homing, granulocyte growth factor-producing T H 2 cells that might be less susceptible to regulation by Treg cells. The clinical implication is that strategies to eliminate effector T H 2 cells might be more effective for the treatment of PA than strategies aimed at expanding the antigen-specific regulatory response.
METHODS

Human subjects
Informed consent was obtained from all subjects or parents/guardians, and all procedures were approved by the institutional review boards at each of the 5 clinical sites. Blood samples were obtained at baseline from a clinical trial conducted by the Consortium of Food Allergy Research (CoFAR) investigating epicutaneous immunotherapy for PA (CoFAR6; ClinicalTrials.gov identifier NCT01904604).
14 Subjects who responded to a double-blind, placebo-controlled food challenge with a cumulative dose of up to 1 g of peanut were categorized as having PA, whereas those who tolerated the challenge were termed high-threshold (HT) subjects. Additional patients with PA and HC subjects were recruited from the Mount Sinai School of Medicine (MSSM) cohort under other institutional review board-approved protocols. MSSM patients with PA were recruited based on a convincing clinical history but did not undergo oral food challenge as part of this study. Subjects' demographics, including peanut-specific IgE levels, are detailed in Table I 
Blood processing and PBMC isolation
For CoFAR6 samples, blood was shipped overnight from participating sites in temperature-controlled boxes (GreenBox; ThermoSafe, Arlington Heights, Ill) with temperature monitors. PBMCs were isolated by means of density centrifugation with Ficoll-Paque Plus (GE Healthcare, Pittsburgh, Pa) and cultured in AIM V medium (Gibco, Grand Island, NY) with 2.5% autologous plasma.
PBMC stimulation
PBMCs were stimulated with 100 mg/mL crude peanut extract or 5 mL/mL anti-CD3/CD28 beads (Invitrogen, Carlsbad, Calif) for 6 hours, 18 hours, 24 hours, or 5 days. Endotoxin was removed from peanut extract by using Detoxi-Gel columns (Thermo Scientific, Waltham, Mass). Residual endotoxin levels measured with the LAL assay (Thermo Scientific) were 14 pg/mL. GolgiPlug (BD Biosciences, San Jose, Calif) was added 4 hours before harvesting. For surface CD154 staining (sorting), blocking anti-CD40 antibody (Miltenyi Biotec, Bergisch Gladbach, Germany) was added to the culture to maintain CD154 at the surface. In some experiments cells were stimulated with rhIL-2 (STEMCELL Technologies, Vancouver, British Columbia, Canada) at 5 ng/mL, or neutralizing anti-IL-2 (R&D Systems, Minneapolis, Minn) was added at 500 ng/mL. Phorbol 12-myristate 13-acetate/ionomycin/brefeldin cocktail (BD Biosciences) was applied for 6 hours to stimulate cells in some experiments.
Flow cytometry
Harvested PBMCs were stained for viability (Live/Dead Fixable stain; Invitrogen), washed and stained for surface markers, and washed for fixation and permeabilization. Cells were fixed in 4% paraformaldehyde (Electron Microscopy Services, Hatfield, Pa) and treated with permeabilization buffer (eBioscience, San Diego, Calif) before staining with labeled antibodies to detect intracellular CD154 and cytokines. For FoxP3 staining, cells were processed with the FoxP3/Transcription Factor Staining Buffer Set (eBioscience) before staining with antibodies. Antibody panels used for surface and cytoplasmic staining are shown in Tables E1-E4 in this article's Online Repository at www.jacionline.org. Stained cells were analyzed subsequently on an LSR Fortessa (BD Biosciences). For Treg cell sorting or depletion, harvested PBMCs were stained with CD4-Alexa Fluor 488 (Clone OKT4; BioLegend, San Diego, Calif), CD25-Alexa Fluor 700 (Clone BC96; BioLegend), and CD127-phycoerythrin-Cy7 (Clone eBioRDR5; eBioscience). Cells were sorted on the FACSAria IIu (BD Biosciences).
Peanut-specific IgE and IgG 4
Frozen plasma samples were thawed, and peanut-specific IgE and IgG 4 levels were measured by using ImmunoCAP (Thermo Fisher Scientific).
Secreted cytokine measurement
Cell-culture supernatants were centrifuged and stored at 2808C. Supernatant cytokines were measured by using the ProcartaPlex Human Cytokine 
Single-cell analysis
RNA-seq raw fastq data were aligned to a hg38 reference genome (UCSC) by using STAR (2.4.2a). Aligned reads were mapped to hg38 genes by using featureCounts from the Subread package (1.4.4). 16 Cells with reads of less than 5 3 10 5 were removed. The negative binomial model-based method edgeR (3.10.0) 15 was used for single-cell differential expression analysis. Genes expressed in at least 1 cell with at least 1 read per million mapped were kept. The relative log expression method was used to calculate normalization factors between samples. We included plates as covariates to account for any confounding effect of subjects in the generalized linear model and performed quasilikelihood F tests for hypothesis testing. Genes with false discovery rates of less than 0.05 were defined as differentially expressed genes (DEGs). The data discussed in this publication have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) 17 and are accessible through GEO Series accession number GSE98852 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? acc5GSE98852).
Molecular state clustering
The Monocle (1.2.0) toolkit was used to find DEGs between cell types/ states and to cluster CD154 1 cell subgroups. 18 Genes expressed at low levels (<1 read per million mapped in 1 subject) were filtered out, and read counts were converted into reads per kilobase per million mapped reads. Independent component analysis was carried out for dimensional reduction of gene expression. DEGs generated with edgeR-QL were fed as guide genes to order the cells.
T-cell receptor clonal inference
T-cell receptor (TCR) clonal analysis was based on TraCeR (0.1). 19 TCR sequences were reconstructed by means of alignment of reads to synthetic human TCR genomes (all possible V-J combinations provided by TraCeR) by using bowtie2 (2.1.0) 20 and assembled reads into TCR contigs by using Trinity (2.2.0). 21 The assembled contigs were then aligned against the IMGT human database by using IgBlast (1.5.0) 22 and quantified as transcripts per million by using kallisto (0.43.0). 23 Only the 2 most highly expressed TCRs from each locus were retained. We searched for cells sharing exact TCR sequences for each cell type.
RESULTS
Peanut-specific T-cell responses and clinical phenotype
Peripheral blood was obtained from a cohort of primarily pediatric patients with PAwho reacted to an oral challenge dose of less than 1 g of peanut (CoFAR cohort), subjects with a history of PA and detectable peanut-specific IgE who tolerated a cumulative dose of 1 g of peanut (HT subjects), and healthy adult control subjects who self-reported tolerance to peanut (HC subjects). The PA and HT groups were obtained from subjects undergoing baseline peanut challenges as part of enrollment screening for CoFAR6, a trial of epicutaneous peanut immunotherapy.
14 Demographic information is shown in Table I .
Freshly isolated PBMCs were cultured with peanut extract for 6 hours, harvested, and stained for surface markers and intracellular cytokines. Peanut-responsive T cells were identified by means of expression of CD154, also known as CD40 ligand, which is upregulated on T cells in response to TCR engagement and is essential for providing T-cell help to B cells. Coexpression of the cytokines IL-4, IL-13, IFN-g, and IL-10 was determined (representative plots of CD154 vs IL-4 and IFN-g are shown in Fig 1, A) . The 6-hour stimulation time point was chosen as optimal for intracellular cytokine detection (see Fig E2 in this article's Online Repository at www.jacionline.org).
We observed a significant increase in numbers of CD154 1 CD4 1 T cells after peanut stimulation in patients with PA but not in HT or HC subjects (Fig 1, B) . Stimulation with egg white protein induced CD154 expression in patients with PA who had egg allergy but not in those who were egg tolerant (data not shown), demonstrating specificity for clinical reactivity. Cytokine expression by CD154
1 T cells in patients with PA was dominated by IL-4 and IL-13, with a low but statistically significant increase in IL-10 levels and no significant IFN-g response (Fig 1, C) . No increase in numbers of CD154 1 cells of any cytokine phenotype was elicited from CD4 1 T cells from HT or HC subjects. The frequency of peanut-responsive CD154 We examined chemokine receptor expression on peanutresponsive T cells from patients with PA to assess homing capacity (Fig 1, D-F) . We examined the marker CCR4, which supports homing to the skin and lung; the mucosal homing marker CCR6; and the B-cell follicle homing marker CXCR5. A significantly greater frequency of peanut-responsive CD4 1 T cells expressed CCR4 and CCR6 compared with the total
CD4
1 T-cell population (Fig 1, E) . This was not due to activation because polyclonally activated CD4
1 T cells did not show a similar enrichment in chemokine receptor frequency (Fig 1, F) . CCR4 and CCR6 were both enriched on activated T H 2 cells (defined as CD154 (Fig 1, E) or anti-CD3/CD28 (Fig 1, F) . Statistics were calculated by using the Friedman test with the Dunn posttest. **P < .01, ***P < .001, and ****P < .0001.
peanut-responsive T H 2 cells from patients with PA include skin, lung, and intestinal homing populations, as well as folliclehoming T cells with the potential to regulate IgE production.
Phenotypic heterogeneity of peanut-responsive T H 2 cells in patients with PA
We recruited additional patients with PA to perform phenotypic analysis of peanut-responsive T cells (MSSM cohort, demographic information in Table I ). Memory and differentiation markers, including CD45RO, CD27, CCR7, CD25, CD161, and chemoattractant receptor-homologous molecule expressed on T H 2 lymphocytes (CRTH2), were examined. CD4
1 T cells upregulating CD154 after peanut exposure were compared with CD4 1 T cells upregulating CD154 after polyclonal stimulation to control for effects of activation (Fig 2, A) . Peanut-activated cells were enriched for the memory marker CD45RO and expressed less CD27 and CCR7 compared with polyclonally activated T cells. CD25 and CD161 expression was also enriched on peanut-activated T cells, although these markers were expressed E, Quantification of secreted cytokines after peanut stimulation of PBMCs from patients with PA (n 5 33), HC subjects (n 5 5), and HT subjects (n 5 3) for 5 days. Statistics were calculated by using the MannWhitney U test. *P < .05, **P < .01, ***P < .001, and ****P < .0001.
by a minority of peanut-responsive T cells. The marker CRTH2, which is constitutively expressed on basophils, eosinophils, and a small subset of CD4 1 T cells (see Fig E4 in this article's Online
Repository at www.jacionline.org), 24, 25 was present on a population of T cells distinct from peanut-responsive T cells (Fig 2, A , and see Fig E4) . Therefore peanut-responsive CD154
1 T cells low by using fluorescence-activated cell sorting) on peanut-induced cytokine secretion. Individual values are shown for patients with PA (MSSM cohort, n 5 10) or HC subjects (n 5 9). *P < .05, **P < .01, ***P < .001, and ****P < .0001. NS, Not significant. Statistics were calculated with the Wilcoxon matched pairs signed-rank test (Fig 3, A and E) or the Friedman test with the Dunn posttest correction (Fig 3, B) . are selectively enriched for effector memory T cells in patients with PA but are heterogeneous and lack unified surface markers. We examined coexpression of IL-5 and IL-9 with IL-4 in peanut-responsive T cells (Fig 2, B-D) . After 6 hours of stimulation with peanut extract, we observed a subset of CD154 (Fig 2, B) . We did not observe IL-5 or IL-9 expression in CD154 1 cells that did not express IL-4, suggesting that these cytokines were derived from T H 2 cells rather than T H 9 subsets. As cells acquired coexpression of IL-5 and IL-9, they became uniformly positive for the memory marker CD45RO and negative for CD27, which is indicative of terminal differentiation (Fig 2, D) . We will refer to these T H 2 cells coexpressing IL-5, IL-9, or both as T H 2 1 cells. For a more comprehensive profile of the effector phenotype of the peanut-specific immune response, we measured cytokines secreted into the culture supernatant using multiplex analysis 5 days after peanut stimulation. A time course of cytokine response demonstrated that T H 2 cytokines were first detectable in supernatants after 4 days of stimulation and were maximal at 5 days (data not shown). PBMCs from patients with PA secreted an array of T H 2-associated (IL-5, IL-9, and IL-13) and proinflammatory (IL-6, GM-CSF, TNF-a, and TNF-b) cytokines (Fig 2, E) . IL-4 levels were less than levels of detection in most samples. Like IL-2, IL-4 consumption in ex vivo cultures has been described 26 and might explain the lack of detectable IL-4. IFNg, IL-10, and IL-17 were detectable, but levels were not significantly increased in response to peanut stimulation, even in HT or HC subjects.
Identification of peanut-responsive CD4
1 T cells bearing regulatory markers CD154 expression has been reported to be expressed on Treg cells with slower kinetics than effector cells. 27 We did not observe expression of CD154 on CD4
1
CD25
hi CD127 low cells at 6 hours of stimulation, but at 18 hours of peanut or polyclonal stimulation, we observed upregulation of CD154 on these cells (see Fig E5 in Fig E5) . We examined the frequency of peanut-responsive cells with Treg cell markers in patients with PA, HT subjects, and HC subjects. We observed a significant increase in CD154 expression after 18 hours of peanut stimulation on CD3
hi CD127 low FoxP3 1 cells from patients with PA, which was lower or absent in HC and HT subjects (Fig 3, A) . Assessment of chemokine receptor expression on CD154
1 cells with regulatory markers showed high expression of CCR4, which was similar to the total population of Treg cells, and levels of CCR6 that were enriched compared with those of either total CD4
1 T cells or total Treg cells (Fig 3, B) . Peanutresponsive cells with Treg cell markers expressed high levels of the memory marker CD45RO, intermediate levels of CD27, and low levels of CCR7, which is consistent with a tissue-homing memory T-cell phenotype (see Fig E6 in 1 T cells and, more strikingly, on Treg cells (Fig 3, C) . Neutralization of IL-2 suppressed CD154 expression on CD4
1 T cells after anti-CD3/CD28 stimulation at 18 but not 6 hours (data not shown) and reduced by approximately 50% the frequency of peanut-responsive Treg cells identified after 18 hours of stimulation with peanut extract (Fig 3, D) . These results indicate that Treg cells upregulate CD154 as a secondary response to release of IL-2, likely from effector cells observed to be activated at 6 hours.
The low frequency of antigen-responsive cells (500-600 cells per million CD4
1 T cells) and limited blood volumes available precluded the performance of suppression assays with purified Treg cells responding to peanut stimulation. As an alternative approach to assess Treg cell function, we depleted PBMCs from patients with PA and HC subjects of CD4
1
CD25
hi CD127 low cells using fluorescence-activated cell sorting before stimulation with peanut extract and determined the effect on cytokine secretion (Fig 3, E) . Peanut-induced IFN-g and IL-17 production was significantly increased in cultures of Treg cell-depleted PBMCs from patients with PA and HC subjects, whereas IL-10 production was slightly but not significantly decreased. Levels of IL-13, which was produced at higher levels in patients with PA, were also increased significantly by Treg cell depletion in both patients with PA and HC subjects. In contrast, secretion of IL-5 and IL-9 was significantly enhanced by Treg cell removal in HC subjects but not in patients with PA.
Single-cell transcriptional profile of peanut-responsive CD4 1 T cells
We observed substantial heterogeneity in the phenotype of peanut-responsive cells as identified by CD154 expression after stimulation with peanut. To exhaustively phenotype these cells at molecular resolution, we performed single-cell RNA-seq on CD154
1 T cells captured after 18 hours of stimulation. After applying quality control measures, single-cell sequencing data were available for 212 peanut-responsive CD154 1 cells from 5 patients with PA and 122 aCD3/CD28-activated CD154 1 cells from 3 patients with PA. As an additional reference population, we sorted CD4
1
CD25
hi CD127 low Treg cells from freshly isolated PBMCs from 4 patients with PA or 4 HC subjects (97 resting Treg cells), for a total of 431 cells (sequencing information can be found in Table E7 in this article's Online Repository at www. jacionline.org).
Next, by using Monocle, 18 a notion of expression-state clustering and evolution was generated with guide genes identified as differentially expressed between resting Treg cells from HC subjects and polyclonally activated T cells from patients with PA (Fig 4, A, and see Fig E7, A) . This comparison was chosen to examine how peanut-responsive T cells would cluster between 2 biologically distinct cell populations, and indeed, 3 states or clusters of cells based on this notion of transcriptional similarity were identified. Cells from different subjects were distributed across all 3 states (see Fig E7, B) . State 1 contained 98% of the resting Treg cell populations (Fig 4, A) 30 primarily identified the 3 input cell types but were not able to effectively subcluster peanut-responsive T cells (data not shown).
We selected only the peanut-activated T cells to identify DEGs between states (Fig 4, B) . The complete DEG list is provided in Supplemental Excel File 1 in this article's Online Repository at www.jacionline.org, and a DEG list comparing all peanutactivated T cells with all polyclonally activated T cells is provided in Supplemental Excel File 2 in this article's Online Repository at www.jacionline.org. State 3, which was comprised mostly but not exclusively of peanut-activated T cells, was a clearly proinflammatory T H 2-associated state. DEGs (false discovery rate < 5%) included IL5, IL9, IL13, IL4, colony-stimulating factor 2 (CSF2), and IL3, as well as the IL-25 receptor (IL17RB). Enrichment analysis identified pathways, including ''regulation of immunoglobulin production'' and ''regulation of JAK-STAT'' cascade (see Table E8 in this article's Online Repository at www.jacionline.org). Pathway analysis of DEGs in state 2 identified cell cycle or cell division (see Table E9 in this article's Online Repository at www. jacionline.org), and DEGs included IL2 and chemokines and cytokines, such as CCL22 and IL17F. Peanut-activated T cells in state 1, which clustered together with resting Treg cells, were not defined by a regulatory gene signature. The top pathways associated with DEGs in peanut-activated cells in state 1 were mitochondrion organization, metabolic process, and DNA strand elongation (see Table E10 in this article's Online Repository at www.jacionline.org), suggesting an early activation state. Identification of 5 clusters rather than 3 did not separate the peanutresponsive T cells from Treg cells in state 1 (data not shown). T H 2 cells express molecules to facilitate homing to the skin, lung, intestine, or B-cell follicles, where we hypothesize that they can promote allergic effector cell expansion (skin and mucosa) or IgE class-switching (follicle). The heterogeneous T-cell effector T-cell response to peanut also includes IL-3 and CSF2, which can also contribute to tissue inflammation through actions on allergic effector cells and dendritic cells (DCs), respectively. These distal effects on effector cells and IgE production would be expected to contribute to symptoms on peanut re-exposure. 31 demonstrated that cells were predominantly in G1 and that clustering was independent of cell cycle (see Fig E9 in this article' s Online Repository at www.jacionline.org).
We reconstructed the full complementarity-determining region 3 directly from the single-cell RNA-seq data to characterize the TCR sequence of the a and b chains (see Fig E10 and Table E11 in this article's Online Repository at www.jacionline.org). Using TraCeR (https://www.github.com/teichlab/tracer), 19 we identified 4 clonal expansions, each comprised of a pair of cells with identical a and b TCR sequences from a single patient with PA (Fig 4, D , and see Fig E11 in this article's Online Repository at www.jacionline.org). Clones were found in all 3 states, and interestingly, pairs of clones were found in different states (see Fig  E11) . Clonality was not uniquely associated with T H 2-polarized cells, and instead, the most highly upregulated gene was PLA2G15 (see Fig E11) , a phospholipase that results in a lymphoproliferative and autoimmune disorder when deleted. 32 
DISCUSSION
We studied the T-cell response to peanut at the cellular and molecular levels in a total of 156 human subjects, including 84 who underwent a double-blind, placebo-controlled food challenge to determine their threshold of clinical reactivity to peanut, and 21 HC subjects. In patients with PA, we identified a peanutresponsive population of highly differentiated T H 2 cells and a delayed IL-2-dependent activation of cells expressing regulatory markers, whereas nonallergic control subjects had a marked absence of peanut-reactive immune response. A summary model that places our findings in the pathogenesis of PA is shown in Fig 5. By using a multifaceted approach to immune profiling, the effector response to peanut, including detection of intracellular and secreted cytokines, as well as single-cell profiling, we identified a highly heterogeneous T H 2 response to peanut in patients with PA, including cells coexpressing IL-5 6 IL-9, which we refer to as T H 2 1 cells (Fig 5) . To our knowledge, this is the first report of single-cell RNA-seq of food allergen-responsive T cells. Previously, transcriptional profiling of peanut-responsive CD4 1 T cells was done on the bulk level by using microarray analysis 12 and on the single cell level by using a panel of allergy-and immune tolerance-focused genes. 11 The identification of peanutresponsive T-cell clones in this exploratory analysis is remarkable because we sequenced a relatively small number of cells (40-50 per patient), cells were activated with a crude peanut extract containing many peanut allergens, and stimulation time did not allow for expansion of allergen-responsive T cells. Although preliminary, the positive identification of peanut-responsive clones prompts additional investigation of more patients with higherthroughput single-cell capture approaches, such as DropSeq, 30 to comprehensively study association of phenotype with TCR specificity.
We found that peanut-responsive cells clustered into 3 states, one of which was enriched for highly differentiated T H 2 cells (state 3). Correlation analysis showed that IL4, IL5, IL9, IL13, and IL17RB were highly coexpressed in peanut-responsive T cells. IL3 and CSF2 (GM-CSF) were also differentially expressed in this T H 2 state but did not correlate with the cluster of other T H 2-related cytokines and might be distinct effector cell phenotypes. Using bulk analysis methods, we recently identified a highly differentiated T H 2 (IL-5 and IL-9) and proinflammatory (TNFa and CSF2) immune profile in cohorts of patients with egg allergy.
10,33 IL-9 is differentially expressed by peanut-responsive T cells from patients with PA, as identified through bulk analysis by using a microarray. 34 Wisniewski et al 6 also identified a multifunctional T H 2 response to peanut in patients with PA by using a proliferation-based flow cytometry approach. The T H 2-associated cytokines we identified as upregulated using single-cell RNA-seq (IL3, IL5, IL9, and CSF2) are critical for the differentiation of granulocytes, including mast cells, eosinophils, and basophils, and we hypothesize that these T cell-derived granulocyte growth factors control the allergic milieu of the skin or mucosa (Fig 5) . IL-9 drives intestinal mastocytosis, is increased in the intestines of patients with food allergy, and is critical for food-induced allergic symptoms.
10,33 OX40 ligand-expressing dendritic cells promote production of IL-3 from naive CD4 1 T cells, which then recruit basophils and promote T H 2 priming of CD4 1 T cells. 35 The role of T cell-derived IL-5, IL-3, CSF2, and TNFa in food allergy remains to be identified. The unique association of the IL-25 receptor IL17RB on these highly differentiated T H 2 cells suggests a role for tissue-derived IL-25 in PA pathogenesis, which is supported by work in animal models of food allergy. 36, 37 IL17RB was also previously reported as highly differentially expressed in peanut-responsive T cells analyzed by using a bulk microarray.
11
The peanut-responsive T H 2 cells described here share several features of cells described as T H 2A and pathogenic effector T H 2 (peT H 2) cells. 7, [38] [39] [40] Common features include multicytokine potential, including IL-5 and IL-9, lack of expression of CD27, and expression of hematopoietic prostaglandin D synthase and IL17RB. Both T H 2A and peT H 2 cells are CRTH2
1
CD161
high , 38, 40 which is distinct from the peanut-responsive T H 2 1 cells described here. peT H 2 cells correlate with eosinophilia and were proposed as a T H 2 phenotype that distinguished T H 2 diseases characterized by allergic inflammation of tissues (eosinophilic gastroenteritis or atopic dermatitis) from an IgE-mediated T H 2 disease (PA). 7, 40 T H 2A cells have been described across distinct allergies, including aeroallergens and peanut. 38 The reason for this discrepancy in expression of CD161 and CRTH2 between peT H 2 cells, T H 2A cells, and the T H 2 1 cells we describe here is not clear. We used an activation-based detection approach, whereas T H 2A cells were identified with a tetramer-based approach, and it is possible that activation downregulates CRTH2 expression. However, we observed CRTH2 expression on phorbol 12-myristate 13-acetate/ionomycin-stimulated CD154 1 cells, and peT H 2 cells have been described to emerge in vitro through multiple rounds of stimulation. 40 Despite the discrepancy in expression of CRTH2 and CD161, which might be related to methods of antigen-specific cell detection or culture conditions, expression of CD45RO
, hematopoietic prostaglandin D synthase-positive, and IL17RB
1 are consistent markers of these allergen-specific T H 2 cells with multicytokine production across multiple studies (including peT H 2, T H 2A, and T H 2 1 cells). Homing plays a key role in T-cell function. We found that peanut-responsive T H 2 cells were enriched for the homing markers CCR4, CCR6, and CXCR5. Although CCR6 is often used as a surface marker of T H 17 cells, previously, we showed that CCR6 is required for homing of pathogenic T H 2 cells to the small intestine and development of food-induced allergic symptoms in mice. 41 CCR4 is expressed on both T H 2 and Treg cells and facilitates homing to the skin 42 and lungs. 43 The skin, lungs, and gastrointestinal tract are common sites of manifestations of food allergy, and we speculate that the homing of T cells producing an array of T H 2-related cytokines contributes to allergic inflammation in the tissues, which contributes to acute responses to food allergen (Fig 5) . Provision of B-cell help by T cells is dependent on homing to B-cell follicles in a CXCR5-dependent manner. IL-4 production by T H 2 cells contributes to allergy in large part through support of IgE class-switching, and T cells require CXCR5 expression to interact with B cells in the follicles of the lymph node. 42 We observed significantly enriched expression of CXCR5 on peanut-responsive T H 2 cells in the blood of patients with PA, although the frequency of these cells was low compared with the total population of peanut-responsive cells. Lymph nodes, such as the tonsils, would likely be more informative than blood on the frequency and phenotype of peanut-specific follicular helper T cells. It would be of interest to compare this CXCR5
1 T H 2 population in those with IgE-mediated versus non-IgE-mediated allergic diseases to foods (ie, milk allergy with immediate hypersensitivity reactions vs milk allergy contributing to eosinophilic esophagitis). We hypothesize that this CXCR5
1 T H 2 population would be uniquely associated with IgE-mediated disease.
Treg cells are thought to be deficient or ''reprogrammed'' in patients with food allergy. 13 We identified a population of cells bearing regulatory markers that upregulated CD154 in a delayed manner compared with T H 2 cells (detectable at 18 vs 6 hours). Deletion of CD25 1 cells before stimulation completely abolished this response, indicating that they expressed Treg cell markers before stimulation. These cells expressed markers consistent with peripherally induced Treg cells.
The delayed kinetics of activation, frequency (approximately 5% of the Treg cell population), and IL-2 dependence suggest that these cells are the result of bystander activation rather than antigen-specific Treg cells. There is conflicting evidence on the antigen specificity of Treg cells. Antigen-specific Treg cells (identified as Treg cells based on regulatory marker expression and lack of cytokine production on stimulation) were identified in human subjects by using an array of MHC class II tetramers specific for self-antigens or microbial antigens. 28 Tetramerpositive Treg cells were identifiable but very rare cells (<1% of tetramer-positive cells for any given antigen). Bacher et al 44 used CD137 (4-1BB) as an activation marker of antigenspecific Treg cells and examined the frequency of Treg cells specific for a variety of antigens and allergens. Treg cells specific for aeroallergens or microbial antigens could be readily found in peripheral blood of healthy subjects, but food-specific Treg cells were markedly few to absent. In contrast to these findings in HC subjects, food allergen-responsive cells with a Treg cell phenotype and regulatory function in suppression assays have been identified by using proliferation assays (carboxyfluorescein isothiocyanate dilution) in allergic patients. 45, 46 In addition, single-cell transcriptional profiling using tetramer-selected cells and a curated panel of genes identified a population of peanutspecific cells with expression of regulatory genes (FoxP3, CD25, IL-10, and IFN-g) in patients with PA. 47 Although our data suggest that Treg cells can be bystander activated, Treg cells as a population are functional and dampen the immune response to peanut.
The potential suppressive role of CD154 on Treg cells remains to be clarified. The fact that cytokines commonly produced by highly differentiated T H 2 cells (IL-5 and IL-9) were less affected by removal of Treg cells in patients with PA suggests that T H 2 1 cells might be more resistant to regulation by Treg cells than other T-cell subsets. Memory T cells have been described to be less susceptible to suppression than naive T cells, 48 and we speculate that as T H 2 cells differentiate to become T H 2 1 cells, they become less susceptible to the regulatory effects of Treg cells. Bacher et al 44 have proposed, based on their findings in the context of birch allergy, that T H 2 cells escape Treg cell control because of differing antigen specificities.
There is little information available on the immune basis of tolerance to foods under homeostatic conditions in healthy human subjects, although a lack of food-specific Treg cells has been documented in healthy subjects. 44 In contrast to patients with PA, we observed a marked absence in T-cell reactivity to peanut in HC subjects, as well as those we termed HT subjects, who were sensitized to peanut and had a clinical history of PA but passed a food challenge with a cumulative dose of 1 g of peanut protein. The HT group was not rechallenged with a higher dose of peanut protein, and therefore we do not know what proportion of this group would react at a higher dose of peanut versus being fully tolerant. Importantly, the HT cohort was consistent in age and diet with the PA cohort, whereas the HC cohort was adult and not avoiding peanut in the diet. Despite the diversity of these 2 control groups in age and diet, they exhibited a consistent absence of T-cell response, as measured based on CD154-based detection or cytokine production. Although the HC group was not matched for age, we did not observe any trend of an association between peanut-specific T-cell response and age within the PA group. Furthermore, the age range of the PA group was 4 to 20 years, with 14 patients older than 13 years. Therefore it is unlikely that the absence of peanut-responsive T cells in the HC group, which was also observed in the HT group, was due to age. This lack of T-cell reactivity was accompanied by relatively low levels (HT) or no (HC) peanut-specific IgE and a low peanutspecific IgG 4 levels. The relative absence of allergen-specific T-cell responses in HC subjects is consistent with 2 previous reports that used MHC class II tetramers or CD154 expression to detect peanut-reactive T cells in HC subjects. 7, 8 Our data suggest that naturally occurring clinical tolerance, whether complete tolerance in adult HC subjects not restricting peanut in the diet or a higher threshold of reactivity to peanut in HT subjects, is characterized by immunologic ignorance or anergy rather than an antigen-specific counterregulatory T H 1 or Treg cell response. This does not rule out a role for Treg cells in the healthy response to foods because our data show that removal of the entire Treg cell compartment enhances the immune response to peanut in HC subjects. Indeed, patients with a variant of immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, who lack functional Treg cells, have been reported to have allergies to multiple foods, clearly showing a role for Treg cells in immune tolerance to foods. 49 However, our data suggest that this regulatory activity might not be limited to antigen-specific Treg cells. In summary, we have identified a heterogeneous population of T H 2, T H 2
1
, and other growth factor-producing peanutresponsive cells the with capacity for tissue and lymph node homing that we postulate play a central role in PA pathogenesis. We did not find evidence for a lack of peanut-responsive Treg cells or disrupted Treg cell response in patients with PA. This is consistent with the findings of Bacher et al, 44 who identified the presence of T H 2 effector cells with different antigen specificity than Treg cells in patients with birch allergy, with no deficiency in numbers or suppressive capacity of Treg cells.
These results have several implications for therapy. The relative resistance of IL-5 and IL-9 to regulation by Treg cells in patients with PA, as well as the lack of detectable antigenresponsive Treg cells in HC and HT subjects, suggests that eliminating or targeting peanut-specific T H 2 cells would be more effective for the treatment of PA than boosting the pool of peanutspecific Treg cells. Tight correlation between the IL-25 receptor and cytokine expression in highly differentiated T H 2 cells, as well as the common finding of IL-25 receptor expression by allergen-specific T cells across multiple studies, suggests IL17RB as a target for modifying the phenotype or eliminating these cells.
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Key messages
d PA was associated with a multifunctional T-cell response, including highly differentiated T H 2 cells producing IL-5 and IL-9, cells expressing CSF2 and IL3, and a delayed IL-2-dependent activation of Treg cells.
d Subjects with a higher threshold of reactivity to peanut, as well as HC subjects, exhibited a lack of peanutspecific T H 2 or Treg cell response, suggesting anergy or deletion as a basis of tolerance.
d The contribution of highly differentiated multicytokineproducing T H 2 cells to the pathogenesis of PA needs further investigation.
